Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/the-role-of-renin-angiotensin-system-blockade-therapy-in-the-bdsdqaxXOf
References (57)
-
F. Gramley, E. Himmrich, H. Mollnau, Cathrin Theis, Matthias Hammwohner, A. Goette (2009)
Recent advances in the pharmacological treatment of cardiac arrythmias.Drugs of today, 45 11
-
E. O’Meara, T. Clayton, M. McEntegart, J. McMurray, C. Lang, S. Roger, James Young, S. Solomon, C. Granger, J. Östergren, B. Olofsson, E. Michelson, S. Pocock, S. Yusuf, K. Swedberg, M. Pfeffer (2006)
Clinical Correlates and Consequences of Anemia in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) ProgramCirculation, 113
-
R.H. Falk (2001)
Atrial fibrillation, 344
-
Mahesh Patel (1989)
An introduction to meta-analysis.Health policy, 11 1
-
L. Hansson, L. Lindholm, T. Ekbom, B. Dahlöf, J. Lanke, B. Scherstén, P. Wester, T. Hedner, U. Faire (1999)
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 studyThe Lancet, 354
-
W. Brabham (2010)
Valsartan for Prevention of Recurrent Atrial FibrillationYearbook of Cardiology, 2010
-
F. Belluzzi, L. Sernesi, P. Preti, F. Salinaro, M. Fonte, S. Perlini (2009)
Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.Journal of the American College of Cardiology, 53 1
-
J. Sterne, M. Egger, G. Smith (2001)
Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis.BMJ, 323 7304
-
M. Lehto, S. Snapinn, K. Dickstein, K. Swedberg, M. Nieminen (2005)
Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience.European heart journal, 26 4
-
D. Speigelhalter, Andrew Thomas, N. Best, D. Lunn (2001)
WinBUGS User Manual: Version 1.4 -
P. Sanders, J. Morton, N. Davidson, Steven Spence, J. Vohra, P. Sparks, J. Kalman (2003)
Electrical Remodeling of the Atria in Congestive Heart Failure: Electrophysiological and Electroanatomic Mapping in HumansCirculation: Journal of the American Heart Association, 108
-
J. Healey, A. Baranchuk, E. Crystal, C. Morillo, M. Garfinkle, S. Yusuf, S. Connolly (2005)
Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-AnalysisJournal of the American College of Cardiology, 45
-
B. Kanna, Mithula Gopalam (2007)
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation.European heart journal, 28 3
-
Dao-jun Cao, Chunying Mu, F. Tong, R. Tang (2008)
[Clinical efficacy of irbesartan and amiodarone in elderly patients with paroxysmal atrial fibrillation].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 33 9
-
M. Egger, G. Smith, Martin Schneider, C. Minder (1997)
Bias in meta-analysis detected by a simple, graphical testBMJ, 315
-
R. Fogari, G. Derosa, I. Ferrari, L. Corradi, A. Zoppi, P. Lazzari, T. Santoro, P. Preti, A. Mugellini (2008)
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation.American journal of hypertension, 21 9
-
Peizhu Xie, S. Shen (2006)
[Effect of combination of Chinese and Western medicines on sinus rhythm maintenance in patients with auricular fibrillation after conversion].Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 26 7
-
S. Julius, S. Kjeldsen, H. Brunner, S. Ekman, J. Laragh, Pelle Stolt, G. Mcinnes, Beverly Smith, F. Plat, M. Schork, M. Weber, A. Zanchetti (2005)
The VALUE Trial -
Mhamad Jibrini, J. Molnar, R. Arora (2008)
Prevention of Atrial Fibrillation by Way of Abrogation of the Renin-Angiotensin System: A Systematic Review and Meta-AnalysisAmerican Journal of Therapeutics, 15
-
S. Yusuf, Iyad Daher (2008)
Thrombolytics for PE and right ventricular dysfunctionThe Lancet, 372
-
E. Vermes, J. Tardif, M. Bourassa, N. Racine, S. Lévesque, M. White, P. Guerra, A. Ducharme (2003)
Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) TrialsCirculation, 107
-
S. Yusuf, K. Teo, C. Anderson, J. Pogue, L. Dyal, I. Copland, H. Schumacher, Dagenais Gr, P. Sleight (2008)
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trialThe Lancet, 372
-
J. Butler, I. Anand, M. Kuskowski, T. Rector, P. Carson, J. Cohn (2010)
Digoxin use and heart failure outcomes: results from the Valsartan Heart Failure Trial (Val-HeFT).Congestive heart failure, 16 5
-
K. Wachtell, M. Lehto, E. Gerdts, M. Olsen, B. Hornestam, B. Dahlöf, H. Ibsen, S. Julius, S. Kjeldsen, L. Lindholm, M. Nieminen, R. Devereux (2005)
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.Journal of the American College of Cardiology, 45 5
-
A. Waldo (2006)
Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-AnalysisYearbook of Cardiology, 2006
-
K. Kumagai, H. Nakashima, H. Urata, N. Gondo, Kikuo Arakawa, K. Saku (2003)
Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation.Journal of the American College of Cardiology, 41 12
-
J. Higgins, D. Altman (2008)
Assessing Risk of Bias in Included Studies -
A. Sutton, K. Abrams (2001)
Bayesian methods in meta-analysis and evidence synthesis.Statistical methods in medical research, 10 4
-
F. Schmidt (2008)
Meta-AnalysisOrganizational Research Methods, 11
-
R. Fogari, A. Mugellini, M. Destro, L. Corradi, A. Zoppi, E. Fogari, A. Rinaldi (2006)
Losartan and Prevention of Atrial Fibrillation Recurrence in Hypertensive PatientsJournal of Cardiovascular Pharmacology, 47
-
J. Healey, C. Morillo, S. Connolly (2005)
Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodelingCurrent Opinion in Cardiology, 20
-
M. Allessie, J. Ausma, U. Schotten (2002)
Electrical, contractile and structural remodeling during atrial fibrillation.Cardiovascular research, 54 2
-
K. Ueng, T. Tsai, Wen-Chung Yu, Chin-Feng Tsai, Ming-cheng Lin, Kuei‐Chuan Chan, C. Chen, Der-Jinn Wu, Chung‐Sheng Lin, Shih‐Ann Chen (2003)
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study.European heart journal, 24 23
-
M. Disertori, R. Latini, S. Barlera, M. Franzosi, L. Staszewsky, A. Maggioni, D. Lucci, G. Pasquale, G. Tognoni (2009)
Valsartan for prevention of recurrent atrial fibrillation.The New England journal of medicine, 360 16
-
V. Thijssen, J. Ausma, M. Borgers (2001)
Structural remodelling during chronic atrial fibrillation: act of programmed cell survival.Cardiovascular research, 52 1
-
P. Havránek (2007)
[Results of the ADVANCE study].Vnitrni lekarstvi, 53 10
-
C. Carlier, Joël Coste, M. Etchepare, B. Périquet, O. Amédée-Manesme (1993)
A randomised controlled trial to test equivalence between retinyl palmitate and beta carotene for vitamin A deficiency.British Medical Journal, 307
-
A. Tveit, I. Grundvold, M. Olufsen, I. Seljeflot, M. Abdelnoor, H. Arnesen, Pål Smith (2007)
Candesartan in the prevention of relapsing atrial fibrillation.International journal of cardiology, 120 1
-
A. Madrid, M. Bueno, J. Rebollo, I. Marín, G. Peña, E. Bernal, Aníbal Rodríguez, L. Cano, J. Cano, P. Cabeza, C. Moro (2002)
Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized StudyCirculation: Journal of the American Heart Association, 106
-
A. Ducharme, K. Swedberg, M. Pfeffer, A. Cohen-Solal, C. Granger, A. Maggioni, E. Michelson, J. McMurray, L. Olsson, J. Rouleau, James Young, B. Olofsson, M. Puu, S. Yusuf (2006)
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.American heart journal, 152 1
-
O. Pedersen, H. Bagger, L. Køber, C. Torp-Pedersen (1999)
Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction.Circulation, 100 4
-
L. Hansson, L. Lindholm, L. Niskanen, J. Lanke, T. Hedner, A. Niklason, K. Luomanmäki, B. Dahlöf, U. Faire, C. Mörlin, B. Karlberg, P-O Wester, Jan-Erik Björck (1999)
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trialThe Lancet, 353
-
R. Fogari, A. Zoppi, A. Mugellini, L. Corradi, P. Lazzari, P. Preti, G. Md (2008)
Comparative Evaluation of Effect of Valsartan/Amlodipine and Atenolol/Amlodipine Combinations on Atrial Fibrillation Recurrence in Hypertensive Patients With Type 2 Diabetes MellitusJournal of Cardiovascular Pharmacology, 51
-
T. Celik, A. Iyisoy, H. Kurşaklioğlu, M. Yilmaz, S. Kose, S. Kılıç, B. Amasyalı, S. Demırkol, E. Işik (2005)
The comparative effects of telmisartan and ramipril on P‐wave dispersion in hypertensive patients: A randomized clinical studyClinical Cardiology, 28
-
R. Schmieder, S. Kjeldsen, S. Julius, G. Mcinnes, A. Zanchetti, T. Hua (2008)
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trialJournal of Hypertension, 26
-
K. Wachtell, B. Hornestam, M. Lehto, D. Slotwiner, E. Gerdts, M. Olsen, P. Aurup, B. Dahlöf, H. Ibsen, S. Julius, S. Kjeldsen, L. Lindholm, M. Nieminen, J. Rokkedal, R. Devereux (2005)
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.Journal of the American College of Cardiology, 45 5
-
J. Sterne, M. Egger, G. Smith (2008)
Investigating and Dealing with Publication and Other Biases -
J. Marin-Neto (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular eventsThe New England Journal of Medicine, 258
-
Brett Cliff, N. Younis, Salam Hama, H. Soran (2012)
The role of the renin–angiotensin system blocking in the management of atrial fibrillationJournal of Drug Assessment, 1
-
C. Lefebvre, E. Manheimer, Julie Glanville (2008)
Searching for Studies -
O. Salehian, J. Healey, B. Stambler, Khalid Alnemer, Khalid Almerri, J. Grover, I. Bata, J. Mann, J. Matthew, J. Pogue, S. Yusuf, G. Dagenais, E. Lonn (2007)
Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.American heart journal, 154 3
-
A. Maggioni, R. Latini, P. Carson, Steven Singh, S. Barlera, R. Glazer, S. Masson, E. Cerè, G. Tognoni, J. Cohn (2005)
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).American heart journal, 149 3
-
Xin Du, T. Ninomiya, B. Galan, Edward Abadir, J. Chalmers, Avinesh Pillai, M. Woodward, M. Cooper, S. Harrap, P. Hamet, N. Poulter, G. Lip, Anushka Patel (2009)
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.European heart journal, 30 9
-
(2008)
a systematic review and metaanalysis -
A. Madrid, I. Marín, C. Cervantes, E. Morell, Jaime Estévez, G. Moreno, Jorge Parajón, Jian Peng, Lilianna Limón, Sebastián Nannini, C. Moro (2004)
Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockersJournal of the Renin-Angiotensin-Aldosterone System, 5
-
(2001)
MetaAnalysis in Context 2nd edn -
(2001)
In Systematic Reviews in Health Care: Meta-Analysis in Context 2nd edn
- Publisher
- Wiley
- Copyright
- © 2010 American Society for Clinical Pharmacology and Therapeutics
- ISSN
- 0009-9236
- eISSN
- 1532-6535
- DOI
- 10.1038/clpt.2010.123
- Publisher site
- See Article on Publisher Site
Abstract
Current evidence suggests that angiotensin‐converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) have emerged as novel drugs for preventing the development of atrial fibrillation (AF). A meta‐analysis was performed of 26 randomized controlled clinical trials evaluating the effect of ACEIs or ARBs on the prevention of AF. Overall, ACEIs and ARBs revealed statistically significant preventive effects on AF (odds ratio (OR), 0.65; 95% confidence interval (CI), 0.55–0.76). The preventive effect was similar in the two classes of drugs (ACEI: OR, 0.68; ARB: OR, 0.69). ACEIs and ARBs showed greater preventive effects on recurrent AF (OR, 0.45; 95% CI, 0.31–0.65) than on new‐onset AF (OR, 0.80; 95% CI, 0.70–0.92). Prevention was greatest in patients with AF who were receiving amiodarone as a basic treatment drug (OR, 0.35; 95% CI, 0.26–0.48). In patients with heart failure, there appeared to be a large effect (OR, 0.497), but the credible interval (CrI) limits were wide (95% CrI, 0.187–1.161).
Journal
Clinical Pharmacology & Therapeutics – Wiley
Published: Oct 1, 2010